How Greenwich Biosciences' New AI Tool Transforms Epilepsy Patients' Art Into Music

A 15-year-old girl named Riley has never spoken a word, yet her paintings tell powerful stories. Living with Lennox-Gastaut syndrome (LGS) and tuberous sclerosis complex (TSC), Riley discovered that art became her voice. Her parents watched her create vibrant artwork, wishing there was a way to help others understand what her brushstrokes expressed. This inspired Greenwich Biosciences to build something extraordinary.

The Innovation: Where Art Meets Technology

unspoken symphony is a web-based platform powered by cutting-edge image-recognition artificial intelligence. Greenwich Biosciences launched this tool specifically for the epilepsy community—particularly individuals living with conditions like LGS, Dravet syndrome, and TSC. The technology works like this: patients upload artwork created through any medium (painting, drawing, digital design), and within seconds, the AI analyzes the image and converts it into a unique melody, translating colors, shapes, and patterns into musical notes.

The result? Each piece of artwork becomes its own symphony. Users can play their melodies directly on the website, download sheet music versions, and even receive animated videos showing the notes dancing across their original artwork. These creations can be shared with family, friends, or posted on social media—giving individuals with limited verbal communication a powerful new way to express themselves and connect.

Why This Matters for the Epilepsy Community

Many people living with epilepsy experience developmental delays or cognitive challenges alongside seizures, making it difficult to communicate verbally. Art and music therapy have long been recognized as alternative forms of self-expression for these individuals. By bridging these two worlds, Greenwich Biosciences created a tool that doesn’t just acknowledge this barrier—it transforms it into an opportunity for connection.

“Getting to know someone who can’t speak presents real challenges for caregivers,” Riley’s father Tim explained. “But through her artwork, we finally found a way to truly connect with Riley. This technology opens doors that didn’t exist before.”

Built on Partnership and Purpose

Greenwich Biosciences didn’t create this alone. The platform launched in collaboration with the Dravet Syndrome Foundation, Epilepsy Foundation, Lennox-Gastaut Foundation, and Tuberous Sclerosis Alliance—organizations deeply embedded in the patient community.

CEO Justin Gover emphasized the company’s philosophy: “Patients are at the center of everything we do. Innovation shouldn’t stop at medicine. We wanted to create something that helps people communicate, express themselves, and feel truly heard in ways that weren’t possible before.”

The website also features a gallery showcasing the unspoken symphonies created by individuals living with LGS, Dravet syndrome, and TSC, celebrating the creativity and resilience of the community.

The Bigger Picture

This move reflects Greenwich Biosciences’ broader commitment to the epilepsy community. As a subsidiary of GW Pharmaceuticals plc, the company brings its EPIDIOLEX® cannabidiol treatment to market while simultaneously investing in quality-of-life innovations. unspoken symphony demonstrates that patient care extends beyond pharmaceuticals—it’s about understanding lived experience and creating meaningful solutions.

For Riley and countless others like her, unspoken symphony represents something profound: a voice they’ve always had, now finally heard.

Visit unspokensymphony.com to learn more or create your own musical expression from artwork.